Studying anal cancer treatment outcomes in people with and without HIV

This trial examined the medical records and treatment histories of patients with anal squamous cell carcinoma (a type of anal cancer), both those living with HIV and those without. Researchers gathered real-world information from patients across different countries to better understand which factors predicted how well treatments worked and what outcomes patients experienced. The study compared different treatment approaches and how they performed in both groups.

There is limited research on what factors influence how anal cancer patients respond to treatment, especially when HIV is involved. This trial was created to fill that gap by collecting data from many patients worldwide, so doctors can better understand the best treatment approaches for people with anal cancer regardless of HIV status.